177 related articles for article (PubMed ID: 27096398)
1. Computed Tomography Appearance of Renal Hybrid Oncocytic/Chromophobe Tumors.
Bhatnagar A; Rowe SP; Gorin MA; Pomper MG; Fishman EK; Allaf ME
J Comput Assist Tomogr; 2016; 40(4):513-6. PubMed ID: 27096398
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe renal cell carcinoma: multiphase MDCT enhancement patterns and morphologic features.
Raman SP; Johnson PT; Allaf ME; Netto G; Fishman EK
AJR Am J Roentgenol; 2013 Dec; 201(6):1268-76. PubMed ID: 24261366
[TBL] [Abstract][Full Text] [Related]
3. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.
Kim JI; Cho JY; Moon KC; Lee HJ; Kim SH
Radiology; 2009 Aug; 252(2):441-8. PubMed ID: 19508984
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
[TBL] [Abstract][Full Text] [Related]
5. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
Choi JH; Kim JW; Lee JY; Han WK; Rha KH; Choi YD; Hong SJ; Yoon YE
Korean J Urol; 2015 Oct; 56(10):695-702. PubMed ID: 26495070
[TBL] [Abstract][Full Text] [Related]
6. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
[TBL] [Abstract][Full Text] [Related]
7. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.
Choudhary S; Rajesh A; Mayer NJ; Mulcahy KA; Haroon A
Clin Radiol; 2009 May; 64(5):517-22. PubMed ID: 19348848
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
Wu J; Zhu Q; Zhu W; Chen W; Wang S
Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
[TBL] [Abstract][Full Text] [Related]
9. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
10. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
11. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
[TBL] [Abstract][Full Text] [Related]
12. Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas?
McGahan JP; Lamba R; Fisher J; Starshak P; Ramsamooj R; Fitzgerald E; Yen P
AJR Am J Roentgenol; 2011 Oct; 197(4):W674-9. PubMed ID: 21940539
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
[TBL] [Abstract][Full Text] [Related]
14. Is there a role of the enhancement degree of the lesion on computerized tomography for the characterization of renal tumors?
Kutman K; Süer E; Bedük Y; Oztürk E; Gülpınar O; Gökçe I; Baltacı S
J Urol; 2013 Feb; 189(2):436-40. PubMed ID: 22982427
[TBL] [Abstract][Full Text] [Related]
15. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis.
Jinzaki M; Tanimoto A; Mukai M; Ikeda E; Kobayashi S; Yuasa Y; Narimatsu Y; Murai M
J Comput Assist Tomogr; 2000; 24(6):835-42. PubMed ID: 11105696
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
[TBL] [Abstract][Full Text] [Related]
17. Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice.
Schober JP; Braun A; Ginsburg KB; Bell S; Castro Bigalli AA; Chen M; Wang R; Magee D; Bukavina L; Handorf E; Yu JQ; Chen DYT; Greenberg RE; Smaldone MC; Viterbo R; Correa AF; Uzzo RG; Kutikov A
J Urol; 2023 Sep; 210(3):438-445. PubMed ID: 37378576
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
Zokalj I; Marotti M; Kolarić B
Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
[TBL] [Abstract][Full Text] [Related]
20. Solid Renal Cell Carcinoma Measuring Water Attenuation (-10 to 20 HU) on Unenhanced CT.
Schieda N; Vakili M; Dilauro M; Hodgdon T; Flood TA; Shabana WM
AJR Am J Roentgenol; 2015 Dec; 205(6):1215-21. PubMed ID: 26587928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
